All India Institute Of Medical Sciences Tender

Work Description - Procurement Of Inj Dinutuximab Beta 20mg

All India Institute of Medical Sciences (AIIMS), New Delhi, a Central Government Ministry/Department, invites open tenders for the procurement of Inj Dinutuximab Beta 20mg, reference number 35/H/Inj Dinutuximab Beta 20mg/2025-26. This procurement falls under the 'Goods' category, specifically Drugs and Pharmaceutical Products. The tender documents, including the Tender Notice and Price Schedule, are available for download from December 20, 2025, until January 12, 2026, at 02:00 PM. Bids must be submitted electronically starting December 20, 2025, and no later than January 12, 2026, at 02:00 PM. A mandatory Earnest Money Deposit (EMD) of ₹50,000 is required, payable to AIIMS Main Grant, New Delhi, with exemptions allowed as per guidelines. The bid opening is scheduled for January 13, 2026, at 02:00 PM, at 1st floor, Main Hospital Store, AIIMS New Delhi, 110029. The contract period is 45 days, and the bid validity period is 270 days. Bidders must submit a scanned copy of the EMD and other required technical documents in Cover 1 and the Price Schedule (BOQ) in Cover 2. This tender is being administered by the Sr. Store Officer (H) on behalf of the Director AIIMS, located at the aforementioned address. The organization allows payment instrument types such as Demand Draft, FDR, Bankers Cheque, and Bank Guarantee.